Resources
SCIENTIFIC STUDIES
Role Of Rheology In Tears & Artificial Tears
Authors: A. Arshinoff, Steve MD, FRCSC; Hofmann, Ilan PhD; Nae, Hemi PhD
Published: May 2021
Rheological Behavior Of Commercial Artificial Tear Solutions
Authors: Arshinoff, Steve MD; Hofmann, Ilan PhD; Nae, Hemi PhD
Published: May 2021
Novel Device Provides Rapid Measure of Tear Osmolarity
Ophthalmology Times Ophthalmology Dry eye
By Nancy Groves
Reviewed by Henry Reis, MD, OD
In Vivo Ocular Surface Osmolarity in a Dry Eye Population
Richard L. Maharaj, OD, FAAO
Clinical Director, eyeLABS Optometry and Center for Ocular Surface Disease
Associate Clinical Adjunct Faculty, University of Waterloo School of Optometry
Performance of an In Vivo Tear Film Osmometer in Normal Ocular Surface Conditions
Henry Reis, MD; Stefanie Grenier, BSc; Daniela Albuquerque, MD
Preliminary clinical study on the efficacy of propolis/aloe vera/chamomile compounded natural eye drops*
Claudio Peruccio
Ophthalmology Referrals, Turin Veterinary Centre, Torino, Italy
Tear Osmolarity: A Clinical Tool for the Diagnosis and Management of OSD
Dr François Piuze O.D.
Maintained concentration: Bill Harvey tries out the I-PEN® osmolarity system a useful addition to clinical practice
Author: Bill Harvey
Published: 01/06/2018 issue of OPTICIAN UK
A Comparison of In Vivo and In Vitro Osmometers for the Assessment of Dry Eye Disease
Henry Reis, MD; Stefanie Grenier, BSc; Daniela Albuquerque, MD
Clinical & Refractive Optometry Volume 28, Number 2, 2017
Validity and Reliability of a Novel Handheld Osmolarity System for Measurement of a National Institute of Standards Traceable Solution
Clara C. Chan, MD, FRCSC, FACS,* Armand Borovik, MBBS, FRANZCO,† Ilan Hofmann, PhD,‡ Eric Gulliver, BSc (Hons),§ and Guillermo Rocha, MD, FRCSC, FACS
NEWS AND PRESS RELEASES
Dechra Veterinary Products Partners with I-MED Pharma
Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with…
I-MED PHARMA OPENS EUROPEAN WAREHOUSE
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud…
I-MED PHARMA TRANSITIONS ITS SURGICAL PRODUCT PORTFOLIO TO KEIR SURGICAL
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud…
I-MED PHARMA IS NAMED AS A TOP OPHTHALMIC SOLUTION PROVIDER OF 2020!
FOR IMMEDIATE RELEASE December 9, 2020, (Montreal, QC, Canada) Article published in December issue of…
I-DROP® PUR GEL NOW AVAILABLE IN THE UAE THROUGH PARTNERSHIP WITH PHARMALINK
MONTREAL, NOVEMBER 20, 2020 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis…
I-MED Pharma launches tearcheck® in Canada – A new standard in dry eye analysis!
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the…
I-MED PHARMA LAUNCHES THE LATEST ADDITION TO THEIR DRY EYE PRODUCT LINE, I-DEFENCE® – A NIGHT-TIME OINTMENT FOR SEVERE CHRONIC DRY EYE DISEASE
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today…
Patented IRPL® Technology Now Available in Canada! E>Eye Laser Gains Health Canada Approval with Exclusive Canadian Distribution Rights for I-MED Pharma
I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud…
I-MED PHARMA TO LAUNCH ITS MOST ADVANCED ARTIFICIAL TEAR TO DATE WITH I-DROP® MGD
MONTREAL, February 03, 2020 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
Montreal, June 17, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-LID ’N LASH®, I-LID ’N LASH® PLUS & I-PEN® NOW AVAILABLE IN SWITZERLAND THROUGH PARTNERSHIP WITH PROLENS AG
MONTREAL, May 28, 2019 I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis…
I-MED Pharma Becomes the Authorized Canadian Distributor for the OrCam MyEye 2
MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
I-MED Pharma Celebrates 30 Years of Providing OSD Solutions to the Global Eye Care Community
MONTREAL, April 1, 2019 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in…
I-MED Pharma Partners with Iogen Oy to Introduce I-DROP®, I-LID ’N LASH®, I-RELIEFTM Therapeutic Eye Mask and the I-PEN® Osmolarity System to the Finnish Market.
MONTREAL, November 1st, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the U.S Market.
I-MED Pharma Partners with Quidel to Introduce I-LID ’N LASH®, I-RELIEF® and SMTube® to the…
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg &…
Quebec Government Supports I-MED Pharma by Helping Fund International Expansion
West Island businesses get financial boost from Quebec Government The Quebec government is giving several…
I-MED Pharma Inc. Announces Partnership with Medicals International
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
Montreal, May 24, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…
I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina
Montreal, April 3, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian Company specializing in…
I-MED Pharma’s I-PEN® Does Not Infringe the TearLab Patent
Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release…
I-MED Pharma Wins Patent Case Against TearLab
Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts…
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
Montreal, January 8, 2018 (Globe Newswire) – I-MED Pharma Inc., a Canadian company specializing in…
BLOG
Treating the Eyes while Healing the Mind Part 2
Seeking Personalized, Holistic Treatment for Ocular and Mental Health, Part II (Written by Sarah Dardarian,…
Treating the Eyes while Healing the Mind Part 1
How DED Can Impact Mental Health, Part I (Written by Sarah Dardarian, I-MED Pharma with…
Dropping Acid on Dry Eye Disease
Written by Sarah Dardarian (Sales and Marketing Specialist, I-MED Pharma) As the understanding of dry…
The Dark Side of the Sun
(Written by Sarah Dardarian, Sales and Marketing Specialist, I-MED Pharma) The summer solstice, which happens…
Beauty and the (Dry Eye) Beast
Written by Sarah Dardarian (Sales and Marketing Specialist, I-MED Pharma) The cosmetics industry is one…
Spring Fashion Update: Ditch The Designer Eye Bags for Allergy-Free Clarity
Many people look forward to the rising temperatures after a long winter season and for…
Stuck Wading Through the Wave of Artificial Tears? Try Surfing Through Rheology!
Written by Sarah Dardarian (Sales & Marketing Specialist, I-MED Pharma) One of the first steps…
No One Wants to Work Overtime! Neither Do Your Eyes!
Even before the onset of the COVID-19 pandemic, we were probably guilty of spending a…
How Tea Tree Oil Can Enhance Your Ocular Hygiene Routine
Eye care professionals understand the importance of having a daily ocular hygiene regimen for patients…
FACE MASKS AND OCULAR HEALTH: THE EFFECTS OF THE PANDEMIC ON OUR EYES
Written by Sarah Dardarian (Sales & Marketing Coordinator, I-MED Pharma) The current coronavirus disease (COVID-19)…
Diagnosing Dry Eye Disease with tearcheck® – Creating a New Standard in Dry Eye Analysis
Written by Sarah Dardarian (Sales & Marketing Coordinator, I-MED Pharma) Despite dry eyes being one…
NIGHTTIME AND DRY EYES: HOW TO PROTECT AND RESTORE YOUR EYES DURING SLEEP
We spend about a third of our lives sleeping, and while the exact purpose of…
How Ocular Hygiene Can Help with Demodex, Blepharitis, and MGD
Dry Eye Disease is a common, worldwide disorder that affects over 6.3 million people in…
The Importance of Daily Ocular Hygiene for Everyone
Do your patients ever wake up with crusty eyelids and clumped up lashes? Do they…
HOW TO BEST MANAGE DRY EYE DISEASE?
Don’t ignore your eye health. Dry eye disease is a common condition that can affect…
How Can IRPL® Technology Positively Impact Eye Care Professionals & Their Dry Eye Patients?
Written by Laura Baldassare (Brand Manager, I-MED Pharma) Being able to offer patients innovative solutions…
5 Tips for Self-Isolating & Managing your Dry Eye Symptoms
Written by Laura Baldassare (Brand Manager, I-MED Pharma) To the essential personnel on the front…
I-MED PHARMA Inc. Website Announcement
I-MED PHARMA Inc., Your Leader in Ocular Surface Disorder Management, is proud to announce the…
